EFFECTS OF FONDAPARINUX AND RIVAROXABAN ON CLOT FORMATION IN FACTOR VIII-DEFICIENT, BUT VON WILLEBRAND FACTOR-SUPPLEMENTED, PLASMA MIMICKING PLASMA SAMPLES OBTAINED FROM HEMOPHILIA A PATIENTS

被引：0
|
作者：
Xu, Zhuo Luan [1 ,2 ]
Gantioqui, Jorell [1 ]
Stevic, Ivan [3 ]
Chan, Anthony [1 ,4 ]
Chan, Howard H. [1 ,5 ]
机构：
[1] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
[2] McMaster Univ, Fac Hlth Sci, Med Sci Grad Program, Hamilton, ON, Canada
[3] Univ Manitoba, Clin Biochem, Winnipeg, MB, Canada
[4] McMaster Univ, Dept Pediat, Div Hematol Oncol, Hamilton, ON, Canada
[5] McMaster Univ, Dept Med, Div Hematol, Hamilton, ON, Canada
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F29
引用
收藏
页码：E409 / E409
页数：1
相关论文
共 50 条
  • [21] Immunogenicity of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate during the Wil-31 Prophylaxis Study in Patients with Von Willebrand Disease
    Khayat, Claudia Djambas
    Robert, Sidonio F., Jr.
    Pavlova, Anna
    BLOOD, 2023, 142
  • [22] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN ELDERLY PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSIS
    Goudemand, J.
    Derlon, A. Borel
    Henriet, C.
    Susen, S.
    Repesse, Y.
    HAEMOPHILIA, 2022, 28 : 109 - 110
  • [23] PURIFICATION OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR FROM HUMAN PLASMA BY ANION-EXCHANGE CHROMATOGRAPHY
    JOSIC, D
    SCHWINN, H
    STADLER, M
    STRANCAR, A
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 662 (02): : 181 - 190
  • [24] FACTOR-VIII-COAGULANT ACTIVITY AND VON WILLEBRAND FACTOR IN POSTEXERCISE PLASMA FROM STANDARD-BRED HORSES
    JOHNSON, GS
    TURRENTINE, MA
    SCULLEY, PW
    THROMBOSIS RESEARCH, 1986, 42 (03) : 419 - 423
  • [25] Recombinant factor VIIa combined with plasma factor XIII stabilize clot formation and increase clot stability in whole blood from patients with severe hemophilia A.
    Sorensen, Benny
    Rojkjaer, Rasmus
    Ingerslev, Jorgen
    BLOOD, 2006, 108 (11) : 309A - 309A
  • [26] Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years
    Kittler, Sabine Friederike Karolin
    Miesbach, Wolfgang
    Bauhofer, Artur
    Becker, Thomas
    Schuettrumpf, Joerg
    Dubovy, Patrick
    Nemes, Laszlo
    Richter, Heinrich
    Koenigs, Christoph
    HAMOSTASEOLOGIE, 2019, 39 (04): : 360 - 367
  • [27] Ex Vivo Evaluation of the Effect of Plasma-Derived Factor VIII/Von Willebrand Factor in Patients with Severe Hemophilia_A on Prophylaxis with Emicizumab By Thrombin Generation Assay
    Bravo, Maria-Isabel
    Raventos, Aida
    Perez, Alba
    Arias-Salgado, Elena G.
    Alvarez Roman, Maria Teresa
    Butta, Nora V.
    Jimenez-Yuste, Victor
    Costa, Montserrat
    Willis, Todd
    BLOOD, 2021, 138
  • [28] Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time
    Souto, JC
    Almasy, L
    Muñiz-Diaz, E
    Soria, JP
    Borrell, M
    Bayén, L
    Mateo, J
    Madoz, P
    Stone, W
    Blangero, J
    Fontcuberta, J
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (08) : 2024 - 2028
  • [29] Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy
    Federici, Augusto B.
    Santoro, Rita Carlotta
    Santoro, Cristina
    Pieri, Lisa
    Santi, Roberto Mario
    Barillari, Giovanni
    Borchiellini, Alessandra
    Tosetto, Alberto
    Zanon, Ezio
    De Cristofaro, Raimondo
    Mairal, Esther
    Mir, Roser
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [30] Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis in factor VIII deficient plasma and in hemophilia a patients?
    Antovic, JP
    Antovic, A
    Blombäck, M
    BLOOD, 2003, 102 (11) : 796A - 797A
12345